European Medical Solutions (LTS:0RGO) 3-Month Share Buyback Ratio: 0.00% (As of Jun. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RGO European Medical Solutions LTS:0RGO
35 GF Score
Price €4.70
GF Value €10.44
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions 3-Month Share Buyback Ratio?

European Medical Solutions LTS:0RGO 35 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates LTS:0RGO with a GF Score™ of 35/100 and a GF Value™ of €10.44. The stock has 2 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

LTS:0RGO
35GF Score
European Medical Solutions LTS:0RGO
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
European Medical Solutions (LTS:0RGO) has a 3-Month Share Buyback Ratio of 0.00 as of Jun. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for European Medical Solutions and its competitors.
Is European Medical Solutions' 3-Month Share Buyback Ratio too high?
European Medical Solutions' current 3-Month Share Buyback Ratio is 0.00. Overall, European Medical Solutions has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' 3-Month Share Buyback Ratio compare to VRTX and REGN?
European Medical Solutions' 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Biotechnology company?
A good 3-Month Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for European Medical Solutions and its competitors. European Medical Solutions's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (LTS:0RGO) has a current 3-Month Share Buyback Ratio of 0.00. The stock's GF Value™ is €10.44, compared to a current price of €4.70 — trading 55% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. European Medical Solutions' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For European Medical Solutions (LTS:0RGO), the current 3-Month Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is European Medical Solutions (LTS:0RGO) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.70 is trading 55% below its estimated GF Value™ of €10.44.

Key valuation signals for LTS:0RGO:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: €10.44 vs. price of €4.70 (55% below fair value)
  • GF Score™: 35/100 with 2 warning signs

No single metric tells the full story. See the LTS:0RGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
35GF Score

Get the complete analysis for LTS:0RGO

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.70
Price
€10.44
GF Value